I agree the stock price isn't pretty, but quite ho
Post# of 154134
(Total Views: 475)
Posted On: 10/16/2019 10:24:21 PM
I agree the stock price isn't pretty, but quite honestly I don't care that much. (well...to some extent I do). When the price is being set by retail investors I don't expect much. All you have to do is read any CYDY message board to see the roller coaster of emotions by retail investors on every little thing NP does or doesn't say. What I'd rather know is the fundamentals are sound. Can the company get to BLA and revenue before running out of funding.
I think they can. Very important people including some well established scientists now have knowledge and an interest in keeping leronlimab on the map.
Dr. Jonah Sacha who is trying to get funding from the Bill and Melinda Gates foundation with his Prep and Cure research. Samsung Biologics saw the data room and made concessions to be the manufacturer. Dr. Patterson and his extensive work with CCR5 and having the old pro 140 as an antagonist for his testing. The Thai red cross in their prep investigation are counting on leronlimab not to fail. Now possibly the Army has an interest.
I have to wait until next february to avoid short term capital gains anyway.
I still have my own deadline of seeing the BLA submitted or a license deal before the end of the year. If neither happens then I most likely take my losses and move on, because either management is stringing us along, or the FDA is. I don't remember the exact words NP used at the rodeo conference but for the BLA he said (paraphrasing) all hurdles have been removed, nothing is standing in their way now of getting exactly what the FDA asked for and filing the BLA.
I think they can. Very important people including some well established scientists now have knowledge and an interest in keeping leronlimab on the map.
Dr. Jonah Sacha who is trying to get funding from the Bill and Melinda Gates foundation with his Prep and Cure research. Samsung Biologics saw the data room and made concessions to be the manufacturer. Dr. Patterson and his extensive work with CCR5 and having the old pro 140 as an antagonist for his testing. The Thai red cross in their prep investigation are counting on leronlimab not to fail. Now possibly the Army has an interest.
I have to wait until next february to avoid short term capital gains anyway.
I still have my own deadline of seeing the BLA submitted or a license deal before the end of the year. If neither happens then I most likely take my losses and move on, because either management is stringing us along, or the FDA is. I don't remember the exact words NP used at the rodeo conference but for the BLA he said (paraphrasing) all hurdles have been removed, nothing is standing in their way now of getting exactly what the FDA asked for and filing the BLA.
(1)
(0)